retatrutide phase 2 trial obesity triple agonist Retatrutide, a (GLP1, GIP, glucagon), just released results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Weight loss with retatrutide as

FDA status, TRIUMPH trial timeline, and expected 2027-2028 approval details Retatrutide Cost Guide Complete pricing breakdown for all sources plus projected commercial cost at FDA approval Retatrutide Dosing Guide Phase 2 protocols, titration schedules, and practical dosing strategies Retatrutide Reconstitution Guide Step-by-step instructions for reconstituting lyophilized retatrutide peptide

They werent just sipping the Kool-Aid (or should I say, soda?)

GLP-1 provides the appetite suppression foundation, but GIP fundamentally changes how the body responds metabolically in ways that dramatically amplify weight loss beyond what GLP-1 alone achieves

These are prescription drugs that mimic the effects of this natural hormone

You do not need a chemistry degree